THE COST-EFFECTIVENESS OF LIVER TRANSPLANTATION COMPARED TO CHEMOTHERAPY FOR NON-RESECTABLE LIVER-ONLY METASTASES AFTER COLORECTAL CANCER (MCRC)

被引：0
|
作者：
Bjornely, G. W. [1 ]
Dueland, S. [1 ]
Line, P. [1 ]
Joranger, P. [2 ]
Fretland, A. [1 ]
Edwin, B. [1 ]
Sorbye, H. [3 ]
Aas, E. [4 ]
机构：
[1] Oslo Univ Hosp, Oslo, Norway
[2] Oslo & Akershus Univ Coll Appl Sci, Oslo, Norway
[3] Univ Bergen, Bergen, Norway
[4] Univ Oslo, Oslo, Norway
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN161
引用
收藏
页码：A441 / A441
页数：1
相关论文
共 50 条
  • [41] Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: A prospective study
    Ruers, Theo J. M.
    Joosten, Joris J.
    Wiering, Bastiaan
    Langenhoff, Barbara S.
    Dekker, Heleen M.
    Wobbes, Theo
    Oyen, Wim J. G.
    Krabbe, Paul F. M.
    Punt, Cornelis J. A.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1161 - 1169
  • [42] Isolated Hyperthermic Hepatic Chemoperfusion in Patients with Colorectal Cancer and Isolated Non-Resectable Liver Metastases
    Babich, A. I.
    Unguryan, V. M.
    Pobedintseva, Yu A.
    Kudlachev, V. A.
    Kruglov, E. A.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2018, 10 (03) : 155 - 159
  • [43] Electrolysis and other local ablative treatments for non-resectable colorectal liver metastases
    Teague, BD
    Wemyss-Holden, SA
    Fosh, BG
    Dennison, AR
    Maddern, GJ
    ANZ JOURNAL OF SURGERY, 2002, 72 (02) : 137 - 141
  • [44] Effectiveness of neoadjuvant chemotherapy including bevacizumab in patients with resectable colorectal cancer liver metastases
    Gruenberger, B.
    Scheithauer, W.
    Tamandl, D.
    Zielinski, C.
    Schueller, J.
    Gruenberger, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC)
    Ksienski, Doran
    Woods, Ryan
    Speers, Caroline
    Kennecke, Hagen
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) : 3085 - 3093
  • [46] Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC)
    Doran Ksienski
    Ryan Woods
    Caroline Speers
    Hagen Kennecke
    Annals of Surgical Oncology, 2010, 17 : 3085 - 3093
  • [47] Conversion from unresectable to resectable liver metastases in real-world patients with liver-only metastatic colorectal cancer (mCRC) treated with FOLFOXIRI plus bevacizumab: The Conversion trial.
    Ahmed, Shahid
    Anderson, Deborah
    Chalchal, Haji I.
    Dwernychuk, Lynn
    Gill, Dilip
    Gitlin, Josh
    Hammond, Austin
    Kanthan, Rani
    Le, Duc
    Lim, June
    Rakheja, Rajan
    Sari, Nazmi
    Vizeacoumar, Franco
    Zaidi, Adnan
    Moser, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [48] Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review
    Bolhuis, Karen
    Kos, Milan
    van Oijen, Martijn G. H.
    Swijnenburg, Rutger-Jan
    Punt, Cornelis J. A.
    EUROPEAN JOURNAL OF CANCER, 2020, 141 : 225 - 238
  • [49] Neoadjuvant chemotherapy in primary resectable colorectal cancer liver metastases
    Gruenberger, Thomas
    Schuell, Birgit
    Kornek, Gabriela
    Scheithauer, Werner
    ANNALS OF ONCOLOGY, 2004, 15 : 97 - 98
  • [50] Chemotherapy in Patients with Resectable Liver Metastases from Colorectal Cancer
    Hebbar, Mohamed
    CURRENT COLORECTAL CANCER REPORTS, 2005, 1 (01) : 34 - 40
12345